Secant Medical, Inc. appointed Jeff Robertson president, effective Monday, October 7, 2013. Robertson has been with the company since August 2011, during which time he has managed the strategic oversight of business development, marketing, client accounts, and operations. He most recently served as vice president, strategic business development.
“We are very pleased to promote Jeff to president of Secant Medical. He has demonstrated strong passion and commitment to the company mission, and has a proven forward-thinking approach to driving new business,” said Karen West, divisional managing director of Solesis Medical Technologies, a division of Fenner, PLC. “Under Jeff’s leadership, we look forward to an exciting future of continued success within our core biomedical textile business, as well as our strategic expansion into novel biomaterials development.” Robertson joined Secant Medical from ARmark Authentication Technologies, LLC, a wholly owned subsidiary of Adhesives Research, Inc. Robertson co-developed ARmark Authentication Technologies in 2005 and served as director and general manager. Previously, Robertson held positions at Adhesives Research as Northeast regional manager, business development manager, and general manager of a global business unit. He began his career in pharmaceutical sales at Bock Pharmaceuticals and Bristol Meyers Squibb.